DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Janjigian YY, Kawazoe A, Yanez PE. et al.
Pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or gastroesophageal junction (G/GEJ) cancer: Initial findings of the global phase 3 KEYNOTE-811 study.
J Clin Orthod 2021;
39 (15, suppl): 4013-4013
We do not assume any responsibility for the contents of the web pages of other providers.